NS, N., M, D., & JJP, K. (2022). Cholesteryl ester transfer protein inhibitors: From high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents? Cardiovascular research, 118(14), 2919. https://doi.org/10.1093/cvr/cvab350
Chicago Style (17th ed.) CitationNS, Nurmohamed, Ditmarsch M, and Kastelein JJP. "Cholesteryl Ester Transfer Protein Inhibitors: From High-density Lipoprotein Cholesterol to Low-density Lipoprotein Cholesterol Lowering Agents?" Cardiovascular Research 118, no. 14 (2022): 2919. https://doi.org/10.1093/cvr/cvab350.
MLA (9th ed.) CitationNS, Nurmohamed, et al. "Cholesteryl Ester Transfer Protein Inhibitors: From High-density Lipoprotein Cholesterol to Low-density Lipoprotein Cholesterol Lowering Agents?" Cardiovascular Research, vol. 118, no. 14, 2022, p. 2919, https://doi.org/10.1093/cvr/cvab350.